• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Sunshine Biopharma Inc. - Common stock (NQ:SBFM)

1.130 +0.010 (+0.89%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 1, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 101,477
Open 1.120
Bid (Size) 1.110 (100)
Ask (Size) 1.160 (800)
Prev. Close 1.120
Today's Range 1.110 - 1.150
52wk Range 1.010 - 24.30
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Health Canada Approves Sunshine Biopharma's Atenolol for Treating and Managing Cardiovascular Conditions
August 31, 2026
From Sunshine Biopharma Inc.
Via ACCESS Newswire
News headline image
A Multibillion-Dollar mRNA Cancer Market Is Taking Shape Targeting Lung Cancer’s Biggest Opportunity
August 26, 2026
EQNX::TICKER_START (NASDAQ:SBFM),(NASDAQ:BNTX),(NYSE:AZN),(NASDAQ:MRNA),(NYSE:BMY) EQNX::TICKER_END 
Via FinancialNewsMedia

Performance

YTD
-91.2%
-91.2%
1 Month
-3.4%
-3.4%
3 Month
-52.7%
-52.7%
6 Month
-90.3%
-90.3%
1 Year
-92.2%
-92.2%

More News

Read More
News headline image
A Multibillion-Dollar mRNA Cancer Market Is Taking Shape Targeting Lung Cancer’s Biggest Opportunity
August 26, 2026
From MarketNewsUpdates.com
Via GlobeNewswire
News headline image
Sunshine Biopharma Reports In Vivo Tumor Suppression with K1.1 mRNA and Advances Novel mRNA-Cancer Vaccine Strategy for Lung Cancer
August 26, 2026
From Sunshine Biopharma Inc.
Via ACCESS Newswire
News headline image
Sunshine Biopharma Receives Canadian Regulatory Approval for Enalapril, Expanding Into $25.94 Billion Global Anti-Hypertensive Drug Market
August 19, 2026
From Sunshine Biopharma Inc.
Via ACCESS Newswire
News headline image
Sunshine Biopharma Launches Amoxicillin in Canada and Begins Pharmacy Shipments, Targeting an Estimated $4.9 Billion Global Market
August 07, 2026
From Sunshine Biopharma Inc.
Via ACCESS Newswire
News headline image
Sunshine Biopharma Enters the $2.8 Billion Global Dienogest Market with Canadian Regulatory Approval
August 04, 2026
From Sunshine Biopharma Inc.
Via ACCESS Newswire
News headline image
Health Canada Approves Sunshine Biopharma's Ondansetron for Treatment of Chemotherapy-Induced Nausea and Vomiting
July 28, 2026
From Sunshine Biopharma Inc.
Via ACCESS Newswire
News headline image
Sunshine Biopharma and University of Arizona Publish Significant New Research Findings
July 20, 2026
From Sunshine Biopharma Inc.
Via ACCESS Newswire
News headline image
Sunshine Biopharma Receives Canadian Regulatory Approval for Generic Arimidex(R)
June 25, 2026
From Sunshine Biopharma Inc.
Via ACCESS Newswire
News headline image
Sunshine Biopharma Announces Canadian Approval for Rivaroxaban, a Generic Form of Xarelto(R)
June 01, 2026
Via ACCESS Newswire
News headline image
Sunshine Biopharma Announces Issuance of U.S. Patent 12,624,066 B2 Covering Novel Coronavirus Treatment Technology
May 29, 2026
Via ACCESS Newswire
Thursday's session: top gainers and losers ↗
May 28, 2026
Via Chartmill
Let's take a look at the stocks that are in motion in today's session. ↗
May 28, 2026
Via Chartmill
Which stocks are gapping on Thursday? ↗
May 28, 2026
Via Chartmill
News headline image
Sunshine Biopharma Announces Reverse Stock Split to Maintain NASDAQ Listing
May 28, 2026
Via ACCESS Newswire
News headline image
Stocks to Watch: NDRA, SBFM, GOVX, HIVE, ANY Trading Actively NOW!
May 26, 2026
Via AB Newswire
Topics Artificial Intelligence
News headline image
ENDRA Life Sciences (NASDAQ: NDRA) Beats Q1 Expectations, TAEUS® Liver Imaging Advances and Strategic Review Acceleration Fuels Investor Awareness
May 26, 2026
Via AB Newswire
News headline image
Stocks Under $1: NXXT, TOON, VRAX, AIM, SBFM on Breakout Watch
May 26, 2026
Via AB Newswire
Topics Artificial Intelligence Intellectual Property
What's going on in today's after hours session ↗
May 21, 2026
Via Chartmill
Most active stocks in Thursday's session ↗
May 21, 2026
Via Chartmill
The trading volume of these stocks is deviating from the norm in today's session. ↗
May 21, 2026
Via Chartmill
There are notable gap-ups and gap-downs in today's session. ↗
May 21, 2026
Via Chartmill
News headline image
Sunshine Biopharma Stock Rallies On Canadian Approval For Generic Amoxicillin ↗
May 21, 2026
Via Benzinga
What's going on in today's pre-market session ↗
May 21, 2026
Via Chartmill

Frequently Asked Questions

Is Sunshine Biopharma Inc. - Common stock publicly traded?
Yes, Sunshine Biopharma Inc. - Common stock is publicly traded.
What exchange does Sunshine Biopharma Inc. - Common stock trade on?
Sunshine Biopharma Inc. - Common stock trades on the Nasdaq Stock Market
What is the ticker symbol for Sunshine Biopharma Inc. - Common stock?
The ticker symbol for Sunshine Biopharma Inc. - Common stock is SBFM on the Nasdaq Stock Market
What is the current price of Sunshine Biopharma Inc. - Common stock?
The current price of Sunshine Biopharma Inc. - Common stock is 1.130
When was Sunshine Biopharma Inc. - Common stock last traded?
The last trade of Sunshine Biopharma Inc. - Common stock was at 09/01/26 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap